Brief: RAPT Therapeutics Announces FDA Clearance to Proceed to Phase 2b Trial of RPT904 in Food Allergy
29/09/2025 11:22
Sept 29 (Reuters) - Rapt Therapeutics Inc RAPT.O: RAPT THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION TO PROCEED TO PHASE 2B TRIAL OF RPT904 IN FOOD ALLERGY Source text: ID:nGNX6VDdLh Further company coverage: RAPT.O ((Reuters.Briefs@thomsonreuters.com;))